Ascentage Pharma Group International (AAPG) Total Liabilities (2023 - 2024)

Historic Total Liabilities for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q4 2024 value amounting to $326.3 million.

  • Ascentage Pharma Group International's Total Liabilities fell 331.61% to $326.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $326.3 million, marking a year-over-year decrease of 331.61%. This contributed to the annual value of $321.1 million for FY2024, which is 661.37% down from last year.
  • Latest data reveals that Ascentage Pharma Group International reported Total Liabilities of $326.3 million as of Q4 2024, which was down 331.61% from $337.5 million recorded in Q4 2023.
  • Over the past 5 years, Ascentage Pharma Group International's Total Liabilities peaked at $337.5 million during Q4 2023, and registered a low of -$57.5 million during Q4 2022.
  • Its 3-year average for Total Liabilities is $202.1 million, with a median of $326.3 million in 2024.
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 68731.14% in 2023, then plummeted by 331.61% in 2024.
  • Quarter analysis of 3 years shows Ascentage Pharma Group International's Total Liabilities stood at -$57.5 million in 2022, then surged by 687.31% to $337.5 million in 2023, then fell by 3.32% to $326.3 million in 2024.
  • Its last three reported values are $326.3 million in Q4 2024, $337.5 million for Q4 2023, and -$57.5 million during Q4 2022.